Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer
OBJECTIVES: To quantify the dose-response relationship of changes in pelvic bone marrow (PBM) functional MR radiomic features (RF) during concurrent chemoradiotherapy (CCRT) for patients with cervical cancer and establish the correlation with hematologic toxicity to provide a basis for PBM sparing....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644624/ https://www.ncbi.nlm.nih.gov/pubmed/36348290 http://dx.doi.org/10.1186/s12885-022-10254-7 |
_version_ | 1784826782450450432 |
---|---|
author | Qin, Xiaohang Wang, Cong Gong, Guanzhong Wang, Lizhen Su, Ya Yin, Yong |
author_facet | Qin, Xiaohang Wang, Cong Gong, Guanzhong Wang, Lizhen Su, Ya Yin, Yong |
author_sort | Qin, Xiaohang |
collection | PubMed |
description | OBJECTIVES: To quantify the dose-response relationship of changes in pelvic bone marrow (PBM) functional MR radiomic features (RF) during concurrent chemoradiotherapy (CCRT) for patients with cervical cancer and establish the correlation with hematologic toxicity to provide a basis for PBM sparing. METHODS: A total of 54 cervical cancer patients who received CCRT were studied retrospectively. Patients underwent MRI IDEAL IQ and T2 fat suppression (T2fs) scanning pre- and post-CCRT. The PBM RFs were extracted from each region of interest at dose gradients of 5–10 Gy, 10–15 Gy, 15–20 Gy, 20–30 Gy, 30–40 Gy, 40–50 Gy, and > 50 Gy, and changes in peripheral blood cell (PBC) counts during radiotherapy were assessed. The dose-response relationship of RF changes and their correlation with PBC changes were investigated. RESULTS: White blood cell, neutrophils (ANC) and lymphocyte counts during treatment were decreased by 49.4%, 41.4%, and 76.3%, respectively. Most firstorder features exhibited a significant dose-response relationship, particularly FatFrac IDEAL IQ, which had a maximum dose-response curve slope of 10.09, and WATER IDEAL IQ had a slope of − 7.93. The firstorder-Range in FAT IDEAL IQ and firstorder-10Percentile in T2fs, showed a significant correlation between the changes in ANC counts under the low dose gradient of 5–10 Gy (r = 0.744, -0.654, respectively, p < 0.05). CONCLUSION: Functional MR radiomics can detect microscopic changes in PBM at various dose gradients and provide an objective reference for bone marrow sparing and dose limitation in cervical cancer CCRT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10254-7. |
format | Online Article Text |
id | pubmed-9644624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96446242022-11-15 Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer Qin, Xiaohang Wang, Cong Gong, Guanzhong Wang, Lizhen Su, Ya Yin, Yong BMC Cancer Research OBJECTIVES: To quantify the dose-response relationship of changes in pelvic bone marrow (PBM) functional MR radiomic features (RF) during concurrent chemoradiotherapy (CCRT) for patients with cervical cancer and establish the correlation with hematologic toxicity to provide a basis for PBM sparing. METHODS: A total of 54 cervical cancer patients who received CCRT were studied retrospectively. Patients underwent MRI IDEAL IQ and T2 fat suppression (T2fs) scanning pre- and post-CCRT. The PBM RFs were extracted from each region of interest at dose gradients of 5–10 Gy, 10–15 Gy, 15–20 Gy, 20–30 Gy, 30–40 Gy, 40–50 Gy, and > 50 Gy, and changes in peripheral blood cell (PBC) counts during radiotherapy were assessed. The dose-response relationship of RF changes and their correlation with PBC changes were investigated. RESULTS: White blood cell, neutrophils (ANC) and lymphocyte counts during treatment were decreased by 49.4%, 41.4%, and 76.3%, respectively. Most firstorder features exhibited a significant dose-response relationship, particularly FatFrac IDEAL IQ, which had a maximum dose-response curve slope of 10.09, and WATER IDEAL IQ had a slope of − 7.93. The firstorder-Range in FAT IDEAL IQ and firstorder-10Percentile in T2fs, showed a significant correlation between the changes in ANC counts under the low dose gradient of 5–10 Gy (r = 0.744, -0.654, respectively, p < 0.05). CONCLUSION: Functional MR radiomics can detect microscopic changes in PBM at various dose gradients and provide an objective reference for bone marrow sparing and dose limitation in cervical cancer CCRT. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10254-7. BioMed Central 2022-11-08 /pmc/articles/PMC9644624/ /pubmed/36348290 http://dx.doi.org/10.1186/s12885-022-10254-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Qin, Xiaohang Wang, Cong Gong, Guanzhong Wang, Lizhen Su, Ya Yin, Yong Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer |
title | Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer |
title_full | Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer |
title_fullStr | Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer |
title_full_unstemmed | Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer |
title_short | Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer |
title_sort | functional mri radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644624/ https://www.ncbi.nlm.nih.gov/pubmed/36348290 http://dx.doi.org/10.1186/s12885-022-10254-7 |
work_keys_str_mv | AT qinxiaohang functionalmriradiomicsbasedassessmentofpelvicbonemarrowchangesafterconcurrentchemoradiotherapyforcervicalcancer AT wangcong functionalmriradiomicsbasedassessmentofpelvicbonemarrowchangesafterconcurrentchemoradiotherapyforcervicalcancer AT gongguanzhong functionalmriradiomicsbasedassessmentofpelvicbonemarrowchangesafterconcurrentchemoradiotherapyforcervicalcancer AT wanglizhen functionalmriradiomicsbasedassessmentofpelvicbonemarrowchangesafterconcurrentchemoradiotherapyforcervicalcancer AT suya functionalmriradiomicsbasedassessmentofpelvicbonemarrowchangesafterconcurrentchemoradiotherapyforcervicalcancer AT yinyong functionalmriradiomicsbasedassessmentofpelvicbonemarrowchangesafterconcurrentchemoradiotherapyforcervicalcancer |